key: cord-0777006-6jr0gk8h
authors: Abbasinia, Mohammad; Hormati, Ahmad; Eshagh Hossaini, Seyed Kamal; Foroghi Ghomi, Seyed Yaser; Zamani, Farhad; Afifian, Mahboubeh; Ahmadpour, Sajjad
title: Clinical Manifestations of Gastrointestinal Symptoms in COVID-19 Patients: An Integrative Review
date: 2021-02-02
journal: Gastroenterol Nurs
DOI: 10.1097/sga.0000000000000584
sha: fbb894f1041e5f1387f82ba4173305d75cd7fca5
doc_id: 777006
cord_uid: 6jr0gk8h

After the outbreak of novel coronavirus disease 2019 (COVID-19) in Wuhan, China, its spread to other countries is rapidly increasing. In this integrative review, we report the prevalence of gastrointestinal symptoms in patients with COVID-19. For this purpose, available articles on gastrointestinal manifestations in patients with COVID-19, which were reported from China, were reviewed. All reviewed articles were searched from December 11, 2019, to June 20, 2020, based on specific key words. Related findings in these articles show that the main target of COVID-19 is lung tissue, as after the virus enters the body, it mainly causes respiratory symptoms in affected patients. But in addition to respiratory symptoms, it is possible that, over time, these patients present with other symptoms, the most obvious of which are gastrointestinal symptoms. It is well documented that diarrhea and vomiting are the most common gastrointestinal symptoms in COVID-19 patients. As part of this report, we also look at the incidence and frequency of gastrointestinal symptoms in COVID-19 patients in Iran. The results can be used by providers as a guideline for better management of gastrointestinal symptoms in these patients.

Several studies have reported the clinical characteristics of patients with COVID-19 (Chang et al., 2020; Guan et al., 2020) . For better management of the disease, recognition of clinical characteristics of COVID-19 can be helpful for clinicians to make proper decisions. One of the complications of this disease in a large group of patients is gastrointestinal (GI) disorders, although not common (Zarifian et al., 2020) . In most studies, it has been reported that patients with COVID-19 have GI symptoms, mainly including diarrhea, nausea, and anorexia, in addition to common respiratory symptoms Chen, Qi, et al., 2020; Meng et al., 2020; Zarifian et al., 2020) .

Studies of the COVID-19 pathogenic mechanism have shown that the virus enters the target cell through angiotensin-converting enzyme-2 (aCE-2) (Hoffmann et al., 2020) . This enzyme has been shown to play a major role in the cleaving of several peptides interfering in the renin-angiotensin pathway. Because the expression of this enzyme in the epithelial cells of the lung, intestine, kidney, and blood vessels is at its highest level, it is not unreasonable to expect that the main target of this virus is the organs that have a high expression of this enzyme (Harmer, Gilbert, Borman, & Clark, 2002) . Lung tissue is one of these organs that have a high overexpression of aCE-2 receptors. although GI manifestations may be less common in some patients, it may be considered the initial sign of infection with SaRS-CoV-2 (Gao, Chen, & Fang, 2020; Gu, Han, & Wang, 2020) . However, studies of these complications have reported a different prevalence for some GI symptoms such as diarrhea .

We included available data on COVID-19 patients confirmed in case reports and retrospective clinical studies relating to the GI presentations in hospitalized patients from China that were published in English between December 11, 2019, and June 20, 2020. Studies that did not discuss GI presentations were excluded.

Data for this review article were searched in the published and unpublished preprint articles up to June 20, 2020, in the PubMed, Scopus, and Google Scholar databases. We performed extensive hand searching of reference lists of articles and reports. The search terms used were "SaRS-CoV-2" and "COVID-19" combined with "gastrointestinal," "clinical characteristics," or "digestive." We identified 28 articles from the initial search that met inclusion and exclusion criteria based on title and abstract. Of these, 11 were duplicates, resulting in 17 studies included for analysis (Table 1) .

We reviewed the 17 eligible Chinese studies and extracted data for province or city, patient age group range and gender, study size, severity of illness, and symptom categories. When extracting information from the studies, pairs of researchers conferred to compare findings and reach consensus. Where consensus was not reached, an independent researcher was consulted.

Literature Review Wang, Fang, et al. (2020) aimed to study the clinical characteristics of noncritical COVID-19 patients who were admitted to Dongxihu Fangcang Hospital, China, between February 7 and 12, 2020. among 1,012 noncritically ill individuals, fever (761 of 1,012; 75.2%) and cough (531 of 1,012; 52.4%) were the most common clinical symptoms. along with these symptoms, the patients presented some GI symptoms including diarrhea, vomiting, and abdominal pain. Diarrhea was the main GI symptom in 152 patients (15%). abdominal pain (37 of 1,012; 3.7%) and vomiting (36 of 1,012; 3.6%) were the other GI symptoms occurring in these patients. The high incidence rate for diarrhea compared with similar studies can be considered as one of the main outcomes of the study. In some published studies, the incidence of diarrhea in patients with COVID-19 ranged from 2% to 10% Liu et al., 2020; Wang, Fang, et al., 2020; Xu, Wu, et al., 2020) . The authors explained that the use of some drugs such as arbidol and moxifloxacin before admission to Fangcang Hospital may be attributed to this high incidence of diarrhea. The research group mentioned that diarrhea, although with a low incidence, should not be ignored in patients with COVID-19, indicating the possibility of fecal-oral transmission. The authors expressed that the severity of the GI symptoms was associated with gender, age, and a history of diabetes and cardiovascular diseases. Guan et al. (2020) described the results of the clinical characteristics of COVID-19 in a selected cohort of patients throughout China. In 1,099 enrolled patients in their study, fever (43.8% on admission and 88.7% during hospitalization) and cough (48.2%) were the most common presenting symptoms (Table 1) . However, diarrhea (3.8%) and nausea or vomiting (5.0%) were the second most common symptoms in these patients. Some patients had high aspartate aminotransferase (aST) levels (>40 U/L; 22.2%), others had high alanine aminotransferase (aLT) levels (>40 U/L; 21.3%), and Gastrointestinal Symptoms in COVID-19 Patients VOLUME 44 | NUMBER 1 | JaNUaRy/FEBRUaRy 2021 E5 some had high total bilirubin levels (>17.1 μmol/L; 10.5%). Findings of this research group demonstrated that patients with more severe conditions showed a higher incidence of diarrhea, as well as higher aST and aLT levels, in comparison with patients with mild conditions (5.8% vs. 3.5% for diarrhea; 28.1% vs. 19.8% for aLT level; 39.4% vs. 18.2% for aST level; and 13.3% vs. 9.9% for total bilirubin). Chen, Zhou, et al. (2020) investigated 99 patients with confirmed cases of 2019 novel coronavirus (2019-nCoV) in Wuhan Jinyintan Hospital, China, from January 1 to 20, 2020. Their study revealed that fever (83%), cough (82%), and dyspnea (31%) were the main symptoms in these patients. also, diarrhea (2%) and nausea and vomiting (1%) were the main presenting GI disorders in the patients.

The epidemiology and initial clinical characteristics of confirmed cases of COVID-19 from January 20 to February 6, 2020, were investigated in Shanghai, China, by Chen, Qi, et al. (2020) . The majority of COVID-19 cases were mild, and a total of 215 (86.3%) patients were discharged after hospitalization. Fever (n = 235; 94.3%), cough (n = 91; 36.5%), and fatigue (n = 39; 15.7%) were the main symptoms in these patients. Diarrhea (n = 8; 3.2%) and loss of appetite (n = 8; 3.2%) were the only GI disorders in these patients. Elevated levels of aLT and aST were also less common in this sample. The researchers found that gender, age, higher levels of white blood cells, as well as C-reactive protein (CRP) and lactate dehydrogenase (LDH), and low levels of albumin could have a significant effect on the severity of symptoms in hospitalized patients in the intensive care unit (ICU). Li et al. (2020) evaluated the relationship between risk factors and mortality rate in adult COVID-19 patients admitted to Tongji Hospital, China, from January 26 to February 5, 2020. They retrospectively enrolled 548 patients (279 patients with severe symptoms and 269 with mild symptoms) in the study and analyzed the findings, as well as followed up until March 3, 2020. The main symptoms in patients were fever (95.2%), fatigue (47.1%), cough (75.7%), and dyspnea (56.6%). Patients with both severe and mild symptoms showed an almost equal number of GI disorders including vomiting (9% vs. 7.4%) and diarrhea (33.7% vs. 31.6%). However, the number of patients with severe conditions presented severe abdominal pain (4.5% vs. 1.4%) as well as hypoalbuminemia (72.9% vs. 45.8%) and higher levels of total bilirubin (12.6% vs. 6.3%) than those with mild symptoms. High levels of albumin (<35 g/L), aLT (>40 U/L), and aST (>40 U/L) were seen in both patient groups with nonsevere and severe conditions reported as 45.8% versus 72.9%, 22.3% versus 24.1%, and 23.3% versus 43.4%, respectively. Meng et al. (2020) aimed to characterize computed tomographic (CT) scan and the clinical course of 58 asymptomatic cases that developed COVID-19 pneumonia retrospectively in patients admitted to the Renmin Hospital, China, between January 1 and February 23, 2020. On admission, patients without any clinical symptoms associated with COVID-19 but who had a history of exposure to SaRS-CoV-2 were confirmed by SaRS-CoV-2 nucleic acid testing and CT scan. These patients were then followed every 3-7 days. Of these, 16 presented with symptoms of low lymphocyte count and high CRP including fever (n = 8 cases; 50%), cough (n = 9 cases; 56.3%), fatigue (n = 8 cases; 50%), shortness of breath (n = 2 cases; 12.5%), and diarrhea (n = 1 case; 6.3%) ( Table 1 ). The authors emphasized the importance of surveillance for COVID-19 in asymptomatic patients with known exposure . Zhang et al. (2020) investigated the clinical characteristics of COVID-19-infected cancer patients (n = 28) admitted to three designated hospitals in Wuhan, China, for quarantine and treatment of COVID-19 from January 13 to February 26, 2020. among the 28 patients enrolled, lung cancer was the most frequent type of cancer (n = 7; 25.0%). The most common symptoms on admission were fever (n = 23; 82.1%), dry cough (n = 22; 81%), fatigue (n = 18; 64.3%), and dyspnea (n = 14; 50.0%). Diarrhea (n = 3; 10.7%) was the main GI disorder reported. He et al. (2020) explored the clinical course and dynamic features of immune status in COVID-19 patients at Renmin Hospital of Wuhan, China, between January 10 and February 13, 2020. This research group aimed to find predictors correlated with severity and prognosis of COVID-19. They collected and analyzed the electronic medical records of 204 patients with COVID-19 pneumonia (nonsevere: n = 135; and severe: n = 69) confirmed by nucleic acid testing, retrospectively. Fever (n = 146; 71.5%) and cough (n = 84; 41.1%) were the main presenting symptoms in the patients. Some patients complained of diarrhea (n = 19; 9.31%) and anorexia (n = 12; 5.8%) with the same severity between patients diagnosed with severe and nonsevere COVID-19 conditions (7.2% vs. 10.3% for diarrhea and 7.2% vs. 5.1% for anorexia). Wu et al. (2020) retrospectively and consecutively investigated the clinical and laboratory characteristics of COVID-19 confirmed cases at hospitals in Jiangsu, China, from January 22 to February 14, 2020. according to their findings, fever (n = 63; 78.7%) and cough (n = 51; 63.7%) were the main symptoms in these patients. No patients had hemoptysis or diarrhea symptoms. Only three patients (3.75%) presented with liver function disorders including elevated aLT or aST levels above the normal range. Liu et al. (2020) conducted a retrospective analysis involving hospitalized children in Wuhan, China, from January 7 to January 15, 2020. a total of 366 hospitalized children (≤16 years of age) were enrolled in the study. High fever (>102.2 °F) and cough were the common clinical characteristics. Vomiting was the main GI symptom presenting in four cases. yang, Cao, et al. (2020) investigated the clinical characteristics and imaging manifestations of hospitalized patients with confirmed COVID-19 infection from January 17 to February 10, 2020, in three tertiary hospitals of Wenzhou City, China. among 149 real-time reverse transcription-polymerase chain reaction (rRT-PCR)-confirmed positive patients, fever (n = 114; 76.5%) and cough (n = 87; 58.3%) were the main presenting symptoms in these patients. Some patients complained of diarrhea (n = 11; 7.3%) and nausea or vomiting (n = 2; 1.3%). Some patients also showed increased aST levels (n = 27; 18.1%), and others showed both increased (n = 12; 12.08%) and decreased (n = 2; 1.34%) levels of aLT. The other disorders in these patients were both increased (n = 3; 2.01%) and decreased (n = 9; 6.04%) levels of albumin.

an et al. (2020) retrospectively investigated data of admitted patients with 2019-nCoV pneumonia from January 17 to 24, 2019, in Renmin Hospital of Wuhan, China. Of a total of nine patients enrolled in the study, all of them had only digestive symptoms with no fever at the onset. The main GI symptom was anorexia (66.7%), with other symptoms including nausea (11.1%), vomiting (11.1%), and diarrhea (11.1%). No patient reported abdominal pain. The median time for onset of digestive symptoms was 2.1 days. all nine patients were admitted to the hospital under isolation, and none of them was transferred to the ICU. as all of these patients presented with GI symptoms at the onset but without fever or other respiratory symptoms; consideration of these atypical symptoms is very important to avoid missed diagnosis and prevent possible transmission of COVID-19 infection. Xia et al. (2020) retrospectively analyzed the clinical and CT features of pediatric inpatients with COVID-19 infection from January 23 to February 8, 2020, in Wuhan Children's Hospital, China. They enrolled 20 pediatric patients in the study. Two of them were asymptomatic neonates with positive results from a pharyngeal swab COVID-19 nucleic acid test but negative CT findings. Fever (n = 12; 60%) and cough (n = 13; 65%) were the most common clinical manifestations among these patients. Diarrhea (n = 3; 15%) and vomiting (n = 2; 10%) were the main GI manifestations. Liver dysfunction reflected as increased levels of aLT (>40 IU/L) occurred in five cases (25%). Chang et al. (2020) investigated the epidemiological and clinical characteristics of COVID-19 infection in 13 patients between January 16 and January 29, 2020, from three hospitals in Beijing, China. Two were children. Twelve patients reported fever (mean = 1.6 days) before hospitalization. Cough (n = 6; 46.2%), upper airway congestion (n = 8; 61.5%), myalgia (n = 3; 23.1%), and headache (n = 3; 23.1%) were the most common symptoms. No patient required respiratory support before being transferred to the specialty hospital after a mean of 2 days. One presented with diarrhea as the main GI disorder (7.7%). Xu, Wu, et al. (2020) investigated the clinical characteristics of infected patients with SaRS-CoV-2 from January 10 to 26, 2020, in Zhejiang Province, China. among 62 patients in their study, fever (n = 48; 77%), cough (n = 50; 81%), expectoration (n = 35; 56%), and muscle pain (n = 32; 52%) were the most common symptoms. Diarrhea (n = 3; 8%) was the main GI symptom. Some patients presented higher levels of aST (n = 10; 16.1%). Song et al. (2020) investigated noncontrast chest CT findings in patients with laboratory-confirmed 2019-nCoV infection performed from January 20 to January 27, 2020, at the Center for Disease Control, Shanghai, China. Of 51 patients enrolled in the study, fever (96%), cough (47%), and muscle pain (31%) were the most common symptoms. Diarrhea (n = 5; 10%), loss of appetite (n = 9; 18%), and nausea and vomiting (n = 3, 6%) were the main GI symptoms presenting in these patients. Wang, Hu, et al. (2020) reported a case series of 138 consecutive hospitalized patients with confirmed 2019-nCoV-infected pneumonia at Zhongnan Hospital of Wuhan University, China, from January 1 to 28, 2020. Of these, 26% of patients required admission to the ICU and 4.3% died. Fever (n = 136; 98.6%), dry cough (n = 82; 59.4%), and muscle pain (n = 96; 69.6%) were the most common symptoms. The other common symptoms included lymphopenia (n = 97; 70.3%), prolonged prothrombin time (n = 80; 58%), and elevated LDH (n = 55; 39.9%). anorexia (n = 55; 39.9%), diarrhea (n = 14; 10.1%), nausea (n = 14; 10.1%), and abdominal pain (n = 3; 2.2%) were the main GI symptoms among the patients. High levels of aLT, aST, and total bilirubin were observed in this population. Findings demonstrated that the patients with severe COVID-19 conditions (n = 36) showed a higher incidence of GI disorders than patients with mild conditions (n = 102).

Disastrous consequences of COVID-19, as a new infectious disease in humans, are rising sharply all over the world . COVID-19 presents extraordinary challenges for healthcare workers (Carnero Contentti & Correa, 2020; Han et al., Gastrointestinal Symptoms in COVID-19 Patients VOLUME 44 | NUMBER 1 | JaNUaRy/FEBRUaRy 2021 E7 2020; Zahidie, Iqbal, & Hussain, 2020) . Respiratory symptoms are the most important manifestations of the disease, and human-to-human transmission is the main way for spread of the virus in the community setting Smargiassi et al., 2020) . From February 21 to June 20, 2020, more than 89,000 cases have been diagnosed with COVID-19 in the authors' country of Iran, with 6,150 deaths reported (Jahangiri, Jahangiri, & Najafgholipour, 2020; Nikpouraghdam et al., 2020; Shojaee et al., 2020) . Staying at home or quarantining in an isolated center and minimizing going out are effective ways to battle the spread of COVID-19 (aminnejad & Hormati, 2020; Hormati, Ghadir, Foroghi Ghomi, et al., 2020; Hormati, Niya, et al., 2020) .

With the outbreak of COVID-19 infection starting in Wuhan, Hubei Province, China, patients were noted to exhibit various clinical symptoms. On the basis of these findings, we hypothesized that COVID-19 has a spectrum of symptoms, with GI symptoms among them. This review focuses on GI symptoms of COVID-19 in China beginning after the first report of this infection there.

after infection with COVID-19, patients may present various spectrum of symptoms (Baj et al., 2020; Xu, Li, Tian, Li, & Kong, 2020) . It is well documented that respiratory symptoms are the main characteristic features of COVID-19, occurring in the majority of patients with cough and fever (Xu, Wu, et al., 2020) . although not the primary symptom, it is well documented that GI symptoms are also consistently manifested with the disease (Redd et al., 2020; Tian, Rong, Nian, & He, 2020) . The main GI complaints include anorexia, diarrhea, vomiting, nausea, abdominal pain, hepatic involvement, and GI bleeding (Hormati et al., 2021; Hormati, Shahhamzeh, afifian, Khodadust, & ahmadpour, 2020; Musa, 2020; Redd et al., 2020) .

Diarrhea is the most common GI symptom reported and may be considered as an initial symptom in some infected patients (D'amico, Baumgart, Danese, & Peyrin-Biroulet, 2020; yang, Zhao, et al., 2020) . In comparison with adults in whom decreased appetite is prominent, vomiting is more prominent in children. Huang et al. (2020) first reported the clinical GI symptoms of COVID-19, noting that only 3% of their patients had diarrhea (Huang et al., 2020) . We previously reported that patients with SaRS-CoV-2 infection can present unusual or pure GI symptoms in the absence of respiratory symptoms Hormati, Shahhamzeh, aminnejad, afifian, & ahmadpou, 2020) . In some patients, GI symptoms (e.g., diarrhea) did not occur due to infection with COVID-19, and other reasons such as the side effects of medications are the likely cause for this symptom .

according to the incidence of some GI symptoms in patients with COVID-19 globally, the authors' country is no exception. after the first outbreak of COVID-19 in Qom City, Iran, the number of patients referred to our GI clinics increased by 20% Hormati, Shahhamzeh, aminnejad, et al., 2020) . The incidence of GI complications during COVID-19 is unexpected, and most of these GI symptoms are resistant to medications. Diarrhea and anorexia were the most common GI symptoms in patients who visited our GI clinic. The incidence of other GI symptoms is less common and includes nausea, vomiting, and hemorrhage. GI bleeding and abdominal pain were more frequent in severely ill patients. We also noticed the incidence of some rare GI symptoms such as hyperbilirubinemia, upper GI bleeding, and dysentery (Hormati et al., 2021) . We noticed that the incidence of GI manifestations was higher in the later stage than in the early stage of the COVID-19 pandemic, and the proportion of GI symptoms in severely affected patients was higher than that in nonsevere patients. Most patients had no respiratory symptoms at the time of referral to our GI clinic and some had GI symptoms . Because these patients were unaware of their COVID-19 infection, these patients were carriers of the disease during the onset of their GI symptoms.

During COVID-19, awareness and diagnosis of the incidence of GI symptoms have an inestimable importance, as timely diagnosis can play a significant role in controlling the spread of the virus. Because COVID-19 is still new and its complications are increasing day by day, in some cases, we find no suitable justification for some GI symptoms. On the basis of this, we relied on other diagnostic methods, such as endoscopy and colonoscopy, to ensure and distinguish the symptoms of the disease from other diseases such as inflammatory bowel diseases or cancer. Because performing these procedures requires a close proximity between the endoscopist, the nurse(s), and the infected patient, the possibility of infection in our clinic personnel is increased (almadi et al., 2020) . as a result, we have attentively used recommended infection control approaches to protect the health of our GI team during risky procedures Hormati, Niya, et al., 2020) .

We have previously reported that reducing close contact is the only effective way to fight the COVID-19 virus (Hormati, Ghadir, Foroghi Ghomi, et al., 2020) . as a result, we have attempted to conduct most of our clinical visits virtually and reserve highrisk diagnostic methods only for emergencies. Over time, another new range of symptoms may emerge with COVID-19, some of which may be related to the GI tract. Based on our analysis of the initial studies emerging from China, particularly related to the manifestation of GI complaints, careful examination and recording of these symptoms can be a way to identify the disease and the pathogenic infectious mechanism of this mysterious disease. ✪

of severe acute respiratory syndrome coronavirus 2 (SaRS-CoV-2) in the USa

Severe acute respiratory syndrome-related coronavirus: The species and its virusesa statement of the Coronavirus Study Group

COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission

Clinical characteristics of coronavirus disease 2019 in China

advances and challenges in the prevention and treatment of COVID-19

Quantitative mRNa expression profiling of aCE 2, a novel homologue of angiotensin converting enzyme

The clinical course and its correlated immune status in COVID-19 pneumonia

SaRS-CoV-2 cell entry depends on aCE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor

Can increasing the number of close contact lead to more mortality in COVID-19 infected patients?

Dysentery as a rare GI symptom found in COVID-19 patients

Preventive strategies used by GI physicians during the COVID-19 pandemic

COV-ID-19 in the endoscopy ward: a potential risk for gastroenterologists

Gastrointestinal presentation in a patient with COVID-19 without respiratory tract symptoms: a case report from Qom

Can COVID-19 present unusual GI symptoms

Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China

Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review

The equal danger of improper use of face mask and use of improper mask. Archives of Clinical Infectious Diseases

COVID-19: specific and non-specific clinical manifestations and symptoms: The current state of knowledge

Immunosuppression during the COVID-19 pandemic in neuromyelitis optica spectrum disorders patients: a new challenge

Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China

Clinical progression of patients with COVID-19 in Shanghai

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Diarrhea during COVID-19 infection: Pathogenesis, epidemiology, prevention and management

Manifestations of digestive system in hospitalized patients with novel coronavirus pneumonia in Wuhan, China: a single-center, descriptive study

2019 Novel coronavirus infection and gastrointestinal tract

Illinois COVID-19 Investigation Team

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

The sensitivity and specificity analyses of ambient temperature and population size on the transmission rate of the novel coronavirus (COVID-19) in different provinces of Iran

Diarrhoea may be underestimated: a missing link in 2019 novel coronavirus

Risk factors for severity and mortality in adult COV-ID-19 inpatients in Wuhan

Detection of COVID-19 in children in early

CT imaging and clinical course of asymptomatic cases with COVID19 pneumonia at admission in Wuhan

Hepatic and gastrointestinal involvement in coronavirus disease 2019 (COVID-19): What do we know till now?

Epidemiological characteristics of coronavirus disease 2019 (COV-ID-19) patients in IRaN: a single center study

Prevalence and characteristics of gastrointestinal symptoms in patients with SaRS-CoV-2 infection in the United States: a multicenter cohort study

Predicting the mortality due to COVID-19 by the next month for Italy, Iran and South Korea; a simulation study

Lung ultrasonography for early management of patients with respiratory symptoms during COVID-19 pandemic

World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19)

Emerging 2019 novel coronavirus (2019-nCoV) pneumonia

Review article: Gastrointestinal features in COVID-19 and the possibility of faecal transmission

Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan

Clinical characteristics of non-critically ill patients with novel coronavirus infection (COVID-19) in a Fangcang Hospital

Coronavirus disease (COVID-2019) situation reports

Modes of transmission of virus causing COVID-19: Implications for IPC precaution recommendations: Scientific brief

Clinical characteristics of imported cases of coronavirus disease 2019 (COVID-19) in Jiangsu Province: a multicenter descriptive study

Clinical and CT features in pediatric patients with COVID-19 infection: Different points from adults

Clinical findings in a group of patients infected with the 2019 novel coronavirus (SaRS-Cov-2) outside of Wuhan, China: Retrospective case series

Full spectrum of COVID-19 severity still being depicted

Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): a multi-center study in Wenzhou city

a case of COVID-19 patient with the diarrhea as initial symptom and literature review

Enteric involvement of coronaviruses: Is faecal-oral transmission of SaRS-CoV-2 possible?

Molecular pathology in the lungs of severe acute respiratory syndrome patients

a familial cluster of infection associated with the 2019 novel coronavirus indicating potential person-to-person transmission during the incubation period

Worsening of the COVID-19 Pandemic in New york City: analysis of response gaps and challenges at the public policy and community levels

Gastrointestinal and hepatic abnormalities in patients with confirmed COVID-19: a systematic review and meta-analysis

Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan

China Novel Coronavirus Investigating and Research Team. (2020). a novel coronavirus from patients with pneumonia in China